Boltwood Capital Management Pfizer Inc Transaction History

Boltwood Capital Management

$336 Million
Q3 2024

A detailed history of Boltwood Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Boltwood Capital Management holds 62,722 shares of PFE stock, worth $1.76 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

62,722

Previous 67,653 7.29%

Holding current value

$1.76 Million

Previous $1.89 Million 4.07%

% of portfolio

0.54%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$27.7 - $31.39 $136,588 - $154,784	-4,931 Reduced 7.29%	62,722 $1.82 Million
Q2 2024 Jul 08, 2024	BUY	$25.26 - $29.6 $6,567 - $7,696	260 Added 0.39%	67,653 $1.89 Million
Q1 2024 Apr 04, 2024	SELL	$25.89 - $29.73 $52,349 - $60,114	-2,022 Reduced 2.91%	67,393 $1.87 Million
Q4 2023 Jan 05, 2024	BUY	$26.13 - $33.94 $146,118 - $189,792	5,592 Added 8.76%	69,415 $2 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $5,776 - $6,751	-180 Reduced 0.28%	63,823 $2.12 Million
Q2 2023 Jul 06, 2023	BUY	$36.12 - $41.79 $8,488 - $9,820	235 Added 0.37%	64,003 $2.35 Million
Q1 2023 Apr 03, 2023	BUY	$39.39 - $51.28 $37,223 - $48,459	945 Added 1.5%	63,768 $2.6 Million
Q4 2022 Jan 06, 2023	SELL	$41.75 - $54.5 $100,617 - $131,345	-2,410 Reduced 3.69%	62,823 $0
Q3 2022 Oct 04, 2022	BUY	$43.76 - $53.42 $22,098 - $26,977	505 Added 0.78%	65,233 $2.86 Million
Q2 2022 Jul 07, 2022	SELL	$46.53 - $55.17 $4,746 - $5,627	-102 Reduced 0.16%	64,728 $3.39 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $79,833 - $98,924	-1,745 Reduced 2.62%	64,830 $3.36 Million
Q4 2021 Jan 10, 2022	SELL	$41.32 - $61.25 $38,634 - $57,268	-935 Reduced 1.38%	66,575 $3.93 Million
Q3 2021 Oct 08, 2021	BUY	$39.25 - $50.42 $4,710 - $6,050	120 Added 0.18%	67,510 $2.9 Million
Q2 2021 Jul 06, 2021	SELL	$35.91 - $40.68 $4,129 - $4,678	-115 Reduced 0.17%	67,390 $2.64 Million
Q1 2021 Apr 05, 2021	SELL	$33.49 - $37.77 $149,197 - $168,265	-4,455 Reduced 6.19%	67,505 $2.45 Million
Q4 2020 Jan 04, 2021	SELL	$33.47 - $42.56 $57,735 - $73,416	-1,725 Reduced 2.34%	71,960 $2.65 Million
Q3 2020 Oct 05, 2020	BUY	$31.75 - $37.25 $2,381 - $2,793	75 Added 0.1%	73,685 $2.7 Million
Q2 2020 Jul 02, 2020	SELL	$30.12 - $36.54 $22,590 - $27,405	-750 Reduced 1.01%	73,610 $2.41 Million
Q1 2020 Apr 07, 2020	SELL	$27.03 - $38.62 $167,072 - $238,710	-6,181 Reduced 7.67%	74,360 $2.43 Million
Q4 2019 Jan 07, 2020	BUY	$32.92 - $37.36 $440,798 - $500,250	13,390 Added 19.94%	80,541 $3.16 Million
Q3 2019 Oct 02, 2019	BUY	$32.49 - $42.13 $16,569 - $21,486	510 Added 0.77%	67,151 $2.41 Million
Q2 2019 Jul 01, 2019	SELL	$36.98 - $41.52 $3,697 - $4,152	-100 Reduced 0.15%	66,641 $2.89 Million
Q1 2019 Apr 02, 2019	SELL	$37.5 - $41.2 $204,450 - $224,622	-5,452 Reduced 7.55%	66,741 $2.83 Million
Q4 2018 Jan 07, 2019	SELL	$38.47 - $43.86 $133,298 - $151,974	-3,465 Reduced 4.58%	72,193 $3.15 Million
Q3 2018 Oct 10, 2018	SELL	$34.47 - $41.81 $46,534 - $56,443	-1,350 Reduced 1.75%	75,658 $3.33 Million
Q2 2018 Jul 06, 2018	SELL	$32.98 - $35.16 $2,902 - $3,094	-88 Reduced 0.11%	77,008 $2.79 Million
Q1 2018 Apr 05, 2018	SELL	$31.91 - $37.02 $7.35 Million - $8.53 Million	-230,315 Reduced 74.92%	77,096 $2.74 Million
Q4 2017 Jan 10, 2018	SELL	$33.26 - $35.29 $46,564 - $49,406	-1,400 Reduced 0.45%	307,411 $11.1 Million
Q3 2017 Oct 10, 2017	BUY	$31.0 - $34.15 $9.57 Million - $10.5 Million	308,811	308,811 $11 Million

Others Institutions Holding PFE

# of Institutions

3,240

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $158B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boltwood Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Boltwood Capital Management with notifications on news.

Account

Boltwood Capital Management Pfizer Inc Transaction History